unanswered questions in the use of adjuvant therapy in early breast cancer
Published 11 months ago • 101 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
1:15
remaining questions regarding the use of adjuvant chemotherapy in breast cancer
-
1:40
unanswered questions in breast cancer
-
1:11
an unanswerable question? adjuvant and neoadjuvant treatment of breast cancer
-
0:48
unanswered questions in the meteora-ii trial
-
8:10
mindact: adjuvant chemotherapy in breast cancer
-
1:51
eleanor interim analysis: real-world study of adjuvant neratinib in her2 /hr early breast cancer
-
1:19
optimizing adjuvant therapy: chemotherapy necessity in hr-positive breast cancer
-
2:07
unanswered questions on the use of immunotherapy in crc
-
2:49
procure: genomic signatures and adjuvant chemotherapy for breast cancer in europe
-
2:20
escalation of adjuvant therapy in hr breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
47:29
optimizing therapy in her2 disease with dr. reshma mahtani
-
0:53
eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer
-
1:51
reflecting on the use of cdk4/6 inhibitors in hr breast cancer
-
5:49
perspectives on the olympia study of adjuvant olaparib in early breast cancer | nadine tung
-
0:57
a post hoc analysis of adjuvant radiation therapy in the keynote-522 study
-
5:32
esmo 2020 expert video report on cdk4 6i in the adjuvant treatment of breast cancer
-
6:40
challenges of adjuvant chemotherapy in older breast cancer patients
-
2:02
chemotherapy with adjuvant therapy in breast cancer